Pair the FDA’s recently updated white paper statement, alongside the promise and commitment from the ASPS, consumers and ASPS members can rest assured they will be provided the best information to help make informed decisions pertaining to silicone gel-filled breast implants. Although it is agreed that breast implants are not lifetime devices, 90% of patients are satisfied with their outcomes from breast implantation and report an improved quality of life.